Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$133.41 +0.0%	$133.49	$99.71 ▼ $141.23	$232.02B	0.73	6.16 million shs	4.61 million shs
AMGN Amgen	$296.52 -0.2%	$282.95	$253.30 ▼ $346.85	$159.70B	0.49	2.85 million shs	2.10 million shs
GILD Gilead Sciences	$113.24 +2.0%	$107.40	$67.65 ▼ $119.96	$138.15B	0.29	7.70 million shs	5.23 million shs
PFE Pfizer	$25.56 -0.2%	$23.82	$20.92 ▼ $31.54	$145.66B	0.58	41.80 million shs	38.34 million shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	-0.20%	-2.10%	-0.19%	+4.89%	+30.59%
AMGN Amgen	+1.38%	+2.23%	+2.30%	+2.03%	-4.64%
GILD Gilead Sciences	-0.64%	-0.60%	-1.24%	+5.52%	+64.41%
PFE Pfizer	+1.51%	+2.32%	+9.63%	+13.82%	-8.29%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABT Abbott Laboratories	4.9149 of 5 stars	2.4	3.0	4.2	4.5	3.4	2.5	2.5
AMGN Amgen	4.5231 of 5 stars	2.2	2.0	3.3	3.9	4.1	2.5	1.3
GILD Gilead Sciences	4.7418 of 5 stars	1.4	3.0	4.2	4.1	4.0	2.5	2.5
PFE Pfizer	4.977 of 5 stars	3.2	3.0	4.2	4.5	3.3	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.76	Moderate Buy	$143.11	7.27% Upside
AMGN Amgen	2.35	Hold	$307.82	3.81% Upside
GILD Gilead Sciences	2.77	Moderate Buy	$111.38	-1.64% Downside
PFE Pfizer	2.45	Hold	$28.55	11.70% Upside

Current Analyst Ratings Breakdown

Latest AMGN, GILD, PFE, and ABT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	ABT Abbott Laboratories	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$140.00 ➝ $145.00
6/27/2025	AMGN Amgen	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$328.00
6/24/2025	AMGN Amgen	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
6/24/2025	AMGN Amgen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$305.00
6/16/2025	ABT Abbott Laboratories	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
6/16/2025	ABT Abbott Laboratories	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$143.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00
5/21/2025	GILD Gilead Sciences	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/21/2025	PFE Pfizer	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $33.00
5/20/2025	AMGN Amgen	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$288.00
5/19/2025	PFE Pfizer	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$27.00 ➝ $26.00

(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$41.95B	5.53	$6.58 per share	20.26	$27.62 per share	4.83
AMGN Amgen	$33.42B	4.77	$30.32 per share	9.78	$10.93 per share	27.13
GILD Gilead Sciences	$28.75B	4.90	$7.00 per share	16.17	$15.44 per share	7.33
PFE Pfizer	$63.63B	2.28	$4.35 per share	5.87	$15.62 per share	1.64

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$13.40B	$7.71	17.30	23.28	2.53	31.89%	19.01%	10.82%	7/17/2025 (Estimated)
AMGN Amgen	$4.09B	$10.96	27.05	13.86	2.69	17.39%	176.11%	12.39%	8/5/2025 (Estimated)
GILD Gilead Sciences	$480M	$4.75	23.84	13.96	0.72	20.76%	51.93%	17.40%	8/6/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.52	8.44	0.93	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest AMGN, GILD, PFE, and ABT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	AMGN Amgen	$5.21	N/A	N/A	N/A	$8.86 billion	N/A
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
7/17/2025	Q2 2025	ABT Abbott Laboratories	$1.25	N/A	N/A	N/A	$11.01 billion	N/A
5/1/2025	Q1 2025	AMGN Amgen	$4.18	$4.90	+$0.72	$3.20	$8.05 billion	$8.15 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/24/2025	Q1 2025	GILD Gilead Sciences	$1.77	$1.81	+$0.04	$1.04	$6.77 billion	$6.67 billion
4/16/2025	Q1 2025	ABT Abbott Laboratories	$1.07	$1.09	+$0.02	$0.76	$10.38 billion	$10.36 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.36	1.77%	N/A	30.61%	54 Years
AMGN Amgen	$9.52	3.21%	N/A	86.86%	14 Years
GILD Gilead Sciences	$3.16	2.79%	N/A	66.53%	10 Years
PFE Pfizer	$1.72	6.73%	N/A	124.64%	16 Years

Latest AMGN, GILD, PFE, and ABT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
6/13/2025	ABT Abbott Laboratories	quarterly	$0.59	1.73%	7/15/2025	7/15/2025	8/15/2025
4/22/2025	GILD Gilead Sciences	quarterly	$0.79	3%	6/13/2025	6/13/2025	6/27/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.26	1.78	1.27
AMGN Amgen	8.70	1.17	0.88
GILD Gilead Sciences	1.16	1.37	1.23
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
AMGN Amgen	76.50%
GILD Gilead Sciences	83.67%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
AMGN Amgen	0.76%
GILD Gilead Sciences	0.27%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	114,000	1.74 billion	1.73 billion	Optionable
AMGN Amgen	28,000	537.71 million	533.62 million	Optionable
GILD Gilead Sciences	17,600	1.24 billion	1.24 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

AMGN, GILD, PFE, and ABT Headlines

Recent News About These Companies

Pfizer Earnings Preview: What to Expect

4 hours ago | msn.com